Skip to main content

miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity.

Maffioletti E, Milanesi E, Ansari A, Zanetti O, Galluzzi S, Geroldi C, Gennarelli M, Bocchio-Chiavetto L

Publication: Front Aging Neurosci (2019) • Vol 11 • Page 366PMID: 32009940View on PubMed

Purpose

This study investigated the effects of patient age, sex, and Alzheimer’s disease diagnosis on plasma levels of microRNA (miRNA, miR)-146a. The correlation between Mini-Mental State Examination (MMSE) scores and plasma miR-146a levels was also investigated.

Conclusion

miR-146a cycle threshold (CT) values were negatively correlated with patient age and differed between males and females in the control group and when all specimens were considered but were not correlated when just patients with Alzheimer’s disease were considered. The correlation of age with miR-146a CTs in the whole and control groups was observed after correcting for patient. miR-146a levels were significantly higher in patients with Alzheimer’s disease than controls but this significance disappeared when analyzed using a subset of age and sex-matched specimens or when age was introduced as a covariate. There was a positive correlation between miR-146a CTs and the MMSE scores in the Alzheimer’s disease group.

Studies (1)

Purpose

This study investigated the effects of patient age, sex, and Alzheimer’s disease diagnosis on plasma levels of miR146a. The correlation between MMSE scores and plasma miR-146a levels was also investigated. Blood was collected after overnight fast from 51 patients with Alzheimer’s disease and 45 non-affected, non-age matched controls into EDTA tubes. Plasma was obtained by an unspecified procedure and spiked with cel-miR-39. Cell-free miRNA was isolated using the NucleoSpin Kit and reverse-transcribed using TaqMan MicroRNA Reverse Transcription Kit. miR-146a and cel-miR-39 were quantified using TaqMan MicroRNA Assays and levels of miR-146a were normalized to cel-miR-39. Two specimens from Alzheimer’s patients were found to be outliers and excluded from further analysis.

Summary of Findings

miR-146a CTs were negatively correlated with patient age in controls (r=-0.512, P=0.0003) and when all specimens were considered (P=-0.432, P=1.4 x 10-5) but were not correlated in patients with Alzheimer’s disease. miR-146a levels were lower in females than males when all specimens were analyzed (0.14 versus 1.60, P=0.002) and in the control group (0.31 versus 2.36, P=0.009) but not in the Alzheimer’s disease group. The correlation of age with miR-146a CTs in the whole and control groups was observed after correcting for patient sex (r=-0.403, P=6.3 x10-5 and CTRL: r=-0.476, P=0.001, respectively). miR-146a levels were significantly higher in patients with Alzheimer’s disease than controls (P=0.02) but this significance disappeared when analyzed using a subset of age and sex-matched specimens or when age was introduced as a covariate. There was a positive correlation between miR-146a CTs and the Mini-Mental State Examination (MMSE) scores in the Alzheimer’s disease group before (r=0.409, P=0.007) and after correction for patient sex (r=0.422, P=0.005).

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Alzheimer's Disease
    Not specified
  • Platforms

    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Alzheimer's disease
    Control
    PreaquisitionPatient age
    48-89 years
    PreaquisitionPatient gender
    Female
    Male
    Real-time qRT-PCR SpecificTargeted nucleic acid
    miR-146a